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Abstract 
Objectives: Pharmacists have been shown to reduce hospital readmission rates and improve adherence rates by providing discharge 
medication counseling and offering services such as a bedside delivery program.1 Hospitals are now penalized by Medicare if patients 
are readmitted within 30 days of discharge, so implementation of these programs have the potential to be financially significant as 
well.2 The primary endpoint of this study is to evaluate the impact of a pharmacist discharge medication counseling bedside delivery 
program on medication adherence rates within a six-week period following discharge. The secondary endpoint focuses on hospital 
readmission rates. The objective of this study is to increase collaboration between community pharmacies and hospitals in order to 
improve the quality of patient care. 
Methods: This study was designed as intervention versus control, whereas the intervention patients were those who received 
counseling from a pharmacist or pharmacist intern and control patients were those who did not within the same time period. Collected 
patient data (n=81) included patients’ demographic data and all disease states, genders, and insurance coverage were encompassed 
by the included patients. Medication adherence was measured at follow-up intervals utilizing the proportion of days covered (PDC) 
equation, where a score of at least 80% is required for optimal therapeutic efficacy. Informed consent was obtained from all participants 
regarding a follow-up telephone call or retrieval of medication records through the pharmacy electronic medication records system 
and hospital electronic medical records system. Approximately 10-15-minute counseling sessions were performed at the time of 
discharge. Follow-up phone calls were conducted for the intervention group at four-weeks and six-weeks post-discharge using an eight-
item Morisky medication adherence survey to discuss medication adherence and side effects experienced. 
 Results: There was a total of 81 patients enrolled in this study. There were 27 patients in the intervention group and 54 patients in the 
control group. These pharmacist-led discharge counseling sessions made a statistically significant difference in medication adherence 
rates (P=<0.001) as calculated using PDC, showing adherence rates of 84.4% in the intervention group and 62.8% in the control group. 
The pharmacist-led discharge counseling sessions did not make a statistically significant difference in hospital readmission rates, 
though investigators do expect to see an impact on clinical and financial endpoints. 
Conclusion: Pharmacist involvement in a bedside delivery program helps to improve medication adherence in patients being discharged 
from a hospital. A PDC of at least 80% is required for optimal therapeutic efficacy in most classes of chronic medications, and only the 
intervention arm reached this threshold.13 Although this study’s sample size was not sufficient to show a statistically significant 
difference in reduced hospital readmission rates for patients receiving a pharmacist-led discharge counseling session, the findings show 
the potential for a clinical impact and improved patient outcomes due to increased adherence rates. 
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Background 
Medication adherence is a serious contributor to healthcare 
related issues. There is an association between non-adherence 
and adverse outcomes, increased hospital readmission rates, 
dissatisfied patients, and increased healthcare costs. Every 
dollar spent on improving medication adherence can save up to 
$37 in direct and indirect future healthcare costs.4 Patient 
adherence to medication can be improved with direct 
pharmacist to patient counseling. A study found a statistically 
significant increase in medication adherence in an intervention  
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group who received pharmacist counseling compared to a 
control group who did not receive counseling.5 Additionally, a 
study showed that participants who receive patient education 
upon discharge have decreased hospital readmission rates as 
well.6  
 
In a study by Fischer, it was noted that almost 30% of recently 
discharged patients fail to pick-up prescriptions prescribed to 
them upon discharge from the hospital, proving poor 
medication adherence rates.7,8 Offering a hospital bedside 
delivery service can curb a large portion of this problem and can 
subsequently reduce hospital readmission rates. A hospital 
bedside delivery service is a program in which pharmacists, 
student pharmacists, and/or technicians deliver filled discharge 
medications from a retail pharmacy directly to the patient in 
their hospital room prior to being discharged. Other advantages 
of a bedside delivery service include increased patient 
satisfaction, increased assistance during transitions of care, and 
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reduced hospital readmissions.9 Several studies have shown 
that pharmacist provision of counseling during this process can 
decrease hospital readmission rates to further reduce 
healthcare costs and improve the overall quality of 
healthcare.10,11 
 
Based on the studies previously mentioned, a pharmacists’ 
impact on discharge medication counseling can lead to an 
increase in medication adherence rates which in turn can 
improve a patients’ quality of life and reduce overall healthcare 
costs. This is a continuation of a pilot study by a former 
Community-Based Pharmacy Resident. 
 
Objectives 
This study utilizes a discharge medication bedside delivery 
counseling program within a community pharmacy located on 
the campus of an urban hospital. The bedside delivery program 
was within a corporate retail pharmacy rather than an internal 
pharmacy located in the hospital, setting this study apart from 
others conducted previously. The primary endpoint of this 
study is to evaluate the impact of a pharmacist discharge 
medication counseling bedside delivery program on medication 
adherence rates within a six-week period following discharge. 
The secondary endpoint focuses on hospital readmission rates. 
 
Methods 
The study received IRB approval and informed consent was 
obtained from all participants. This study involves patients 
receiving discharge medication counseling with the bedside 
delivery of their medications from a corporate retail pharmacy 
from June 1, 2019 through July 31, 2019. The process begins 
with a patient being discharged from the hospital. The 
community pharmacy receives discharge prescriptions via fax 
or while attending rounds. The community pharmacy 
employees contact the patient to obtain insurance, payment, 
and demographic information and then subsequently fill the 
prescriptions. A student pharmacist or pharmacist delivers the 
medications to the patient at bedside in the hospital within one 
hour of discharge and offers counseling. The control patients in 
this study are those who receive their discharge medication 
delivery from a pharmacy technician and do not receive 
counseling from a pharmacist. The intervention patients in this 
study are those who have a pharmacist or student pharmacist 
personally deliver the medication(s) and provide bedside 
counseling. The patient receives a follow-up phone call from 
the pharmacy within 4-6 weeks following discharge.  
 
Follow-up phone calls utilize the Morisky Medication 
Adherence Survey as a guide (See Figure 1).12 The data collected 
was analyzed using an intervention (pharmacist and student 
pharmacists provided counseling) versus control (pharmacy 
technicians delivered the medications and no counseling was 
provided) design, and included patients’ multiple disease 
states, gender, and insurance information. Exclusion criteria 
included women who are pregnant, in labor, or nursing due to 
the typical medications prescribed for this population being 
acute, as well as patients who are under 18 years old. The 
primary outcome of this study is to observe the impact of 
pharmacist delivered discharge medication bedside counseling 
on medication adherence measured using the proportion of 
days covered (PDC) equation (See Figure 2).13 PDC is a ratio that 
calculates the number of days covered by a medication 
compared to the total number of days in a period. The 
secondary outcome of this study is to determine if pharmacist 
led discharge medication bedside counseling decreases hospital 
readmission rates within the study’s host health system. Either 
a follow-up telephone call or retrieval of medication records 
through the pharmacy electronic medication records system 
and/or the hospital electronic medical records system was 
conducted at four-weeks and six-weeks post-discharge to 
monitor medication adherence using the PDC equation.  These 
databases were also accessed to determine if the patient was 
readmitted to the hospital during this same time period. 
Approximately 10-15-minute counseling sessions were 
performed at the time of discharge. Another 10-15-minute 
follow-up telephone call took place four-weeks and six-weeks 
post-discharge to discuss medication adherence and side 
effects experienced using the Morisky medication adherence 
survey as a guide. Statistical analysis included a one-sided t-test 
for the primary endpoint and a Chi-squared calculation and 
relative risk reduction for the secondary endpoint. 
 
Results 
There was a total of 81 patients included in the study; 27 
patients were included in the intervention arm and 54 patients 
were included in the control arm (See Figure 3). Patients 
included were in all units of the hospital and had variable 
durations of admission and medical histories. A total of 34 
patients received short term medications (antibiotics or pain 
medications): eight in the intervention arm and 26 in the 
control arm. These patients total period used to calculate PDC 
were only as long as the acute medications were prescribed. A 
total of 47 patients received long term maintenance 
medications: 19 in the intervention arm and 28 in the control 
arm. For the primary endpoint, using the proportion of days 
covered equation for only long-term medications, 62.8% of 
days were covered in the control arm and 84.4% of days were 
covered in the intervention arm. Adherence rates of 80% or 
more are needed for optimal therapeutic efficacy, and only the 
intervention arm reached this threshold.13 These results are 
statistically significant with a p value of <0.001 using a one-
sided t-test (See Figure 4). For the secondary endpoint, hospital 
readmission rates, the intervention arm experienced a 3% 
(1/27) readmission rate and the control arm experienced a 24% 
(13/54) readmission rate with a p value of 0.22 using a Chi-
square calculation. The relative risk reduction is 15.4% (See 
Figure 5).  
 
Discussion  
These results are both statistically and clinically significant as 
the difference in percent of patients readmitted was quite 
large, and hospital readmission rates are an important factor in 
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hospital quality ratings and reducing healthcare costs. 
Limitations of this study include difficulty following-up with 
patients via a telephone call. This is likely due to the fact that 
this patient population is rather transient given the low average 
income of the patients in this health system. Potentially, an 
email address or contact information for a follow up primary 
care physician could have been gathered early in the study 
during the initial in-person interaction to ensure more patients 
could be reached for follow-up care. The use of many short-
term medications such as antibiotics and analgesics also made 
the four-week and six-week follow-up intervals and PDC 
calculations more complicated since patients typically only take 
these medications for 7-10 days post-discharge. Excluding 
short-term medications may be an option for future iterations 
of this study to remedy this particular limitation. The limited 
time period for data collection resulted in a small sample size 
which gave rise to the lack of statistical significance for the 
secondary endpoint. Future iterations of this study should be 
conducted over a longer period of time, in an effort to increase 
the overall sample size.  
 
Conclusions 
Appropriate counseling from pharmacists and/or student 
pharmacists (to include medication use, potential side effects, 
what to expect, etc.) upon hospital discharge increases 
medication adherence rates and therefore therapeutic efficacy. 
The involvement of a pharmacist and/or student pharmacist 
can also potentially decrease hospital readmission rates, 
though the sample size for this study was not large enough to 
prove statistical significance in this endpoint. The clinical 
significance of this study also highlights the potential for 
reduced healthcare costs due to a decrease in hospital 
readmission rates when patients receive discharge bedside 
counseling from a pharmacist and/or student pharmacist.  
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Figure 1: Morisky Medication Adherence Survey 
 
 
 
 
 
 
 
 
 
Figure 2: Proportion of Days Covered Equation 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PDC = (Number of days in period “covered” by 
medication/Number of total days in period) * 100 
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Figure 3: Proportion of Days Covered (adherence rates) results, P=<0.001 
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Figure 4: Hospital readmission rates results, P=0.022 
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Figure 5: Patients included in Control vs. Intervention groups 
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